Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| SUMMER INFAN | SUMR | 6.33% |
| FEDERAL MOGU | FDML | 6.24% |
| NEW ORIENTAL | EDU | 5.60% |
| NATUS MEDICA | BABY | 5.34% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Given Imaging ( GIVN ) , a producer of gastrointestinal products and a developer of capsule endoscopy, recently announced that the Food and Drug Administration (“FDA”) provided updated clearance for its PillCam SB video capsule, including a clearance to encourage its usage for checking lesions that may indicate Crohn’s disease.
The PillCam SB capsule has been marketed since 2001 for visualization of the small bowel mucosa. It can be employed as a tool for detecting abnormalities in the small bowel of adults and children above 2 years of age. The latest labeling is an outcome of the sizeable body of clinical information backing the use of PillCam capsule endoscopy for visualization of lesions arising from a number of indications, including Iron Deficiency Anemia, Crohn’s disease and obscure gastrointestinal bleeding.
Crohn’s disease, which is a chronic condition, leads to inflammation of the lining of the wall of the small intestine. It is accompanied by symptoms such as stomach ache, diarrhea, loss of weight and bleeding of the rectum. Approximately one-half of the cases of Crohn’s disease are detected in the final portion of the small intestine. It is estimated that the condition afflicts half a million Americans.
There is no cure for the disease whose cause is largely unknown; but according to a popular theory, the immune system reacts to a bacterium or virus that causes the inflammation.
Iron Deficiency Anemia is a frequently occurring form of anemia where the victim is short of sufficient healthy red blood cells. The body’s capability to carry oxygen is impacted by the shortage of iron in the blood thereby causing weakness, tiredness, lightheadedness and irritability. Occult gastrointestinal bleeding is marked by bleeding from the digestive tract. The source of bleeding is often unknown and there are many potential causes.
The PillCam capsules are small video cameras that are ingested by patients. The PillCam SB video capsule, which is frequently used for small bowel evaluation, weighs under 4 grams. The second generation PillCam SB 2 includes an imaging device and source of light. It is capable of transmitting two images every second to generate over 50,000 images during a procedure.
Given Imaging promotes gastrointestinal visualization by manufacturing patient-friendly tools based on its PillCam Platform. The PillCam Colon, which is an investigational device, is intended to visualize the colon. Other capsule products from the company include Agile patency capsule, to establish intestinal patency, and Bravo, which is the only commercially available, catheter-free, wireless, 48-hour pH test, for pH testing to measure gastroesophageal reflux disease.
Given Imaging took over Sierra Scientific Instruments in April 2010. The company is headquartered in Yoqneam, Israel with operations in different regions of the globe. Given Imaging faces competition from other existing know how for detecting gastrointestinal disorders. Its main competitors include General Electric Healthcare Systems, a unit of General Electric Co. ( GE - Analyst Report ) , Siemens Medical Solutions, a division of Siemens AG ( SI - Analyst Report ) , and Philips Medical Systems Ltd, a unit of Philips ( PHG - Analyst Report ) .
Read the full Analyst Report on SI
Read the full Analyst Report on PHG
Read the full Analyst Report on GE
Read the full on GIVN